| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Stress Protein Group, Joint Center for Radiation Therapy, Boston, Massachusetts 02115
We have investigated the effect of chemotherapeutic and DNA damaging agents on binding of the tumor suppressor phosphoprotein p53 to its consensus DNA sequence. Activation of p53-DNA binding was seen for treatment with radiation, hydrogen peroxide, actinomycin D, Adriamycin, etoposide, camptothecin, 5-fluorouracil, mitomycin C, and cisplatin. These results showed that DNA strand breaks were sufficient to lead to increased levels of p53. The protein synthesis inhibitor cycloheximide blocks the increase in p53 following DNA damage. The increase in p53 activation in camptothecin treated cells may result, at least in part, from an increased half-life of the protein and consequent increases in intracellular protein concentration.
1 Supported by NIH Grants R29CA-44940 and ROI 47407. R. B. T. was supported by an ASTRO Research Fellowship from the American Society for Therapeutic Radiology and Oncology.
2 To whom requests for reprints should be addressed, at Joint Center for Radiation Therapy, 50 Binney Street, Boston, MA 02115.
Received 2/19/93. Accepted 4/ 1/93.
This article has been cited by other articles:
![]() |
S. Bottger, E. Jerszyk, B. Low, and C. Walker Genotoxic Stress-Induced Expression of p53 and Apoptosis in Leukemic Clam Hemocytes with Cytoplasmically Sequestered p53 Cancer Res., February 1, 2008; 68(3): 777 - 782. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-S. Lee, J. Wan, B.-J. Kim, M.-A. Bae, and B. J. Song Ubiquitin-Dependent Degradation of p53 Protein Despite Phosphorylation at Its N Terminus by Acetaminophen J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 202 - 208. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rivera and S. A. Maxwell The p53-induced Gene-6 (Proline Oxidase) Mediates Apoptosis through a Calcineurin-dependent Pathway J. Biol. Chem., August 12, 2005; 280(32): 29346 - 29354. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Ghosh, S. Bhattacharyya, and J. Varga The Tumor Suppressor p53 Abrogates Smad-dependent Collagen Gene Induction in Mesenchymal Cells J. Biol. Chem., November 12, 2004; 279(46): 47455 - 47463. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chavez-Reyes, J. M. Parant, L. L. Amelse, R. M. de Oca Luna, S. J. Korsmeyer, and G. Lozano Switching Mechanisms of Cell Death in mdm2- and mdm4-null Mice by Deletion of p53 Downstream Targets Cancer Res., December 15, 2003; 63(24): 8664 - 8669. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Bronder and R. G. Moran A Defect in the p53 Response Pathway Induced by de Novo Purine Synthesis Inhibition J. Biol. Chem., December 5, 2003; 278(49): 48861 - 48871. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Freie, X. Li, S. L. M. Ciccone, K. Nawa, S. Cooper, C. Vogelweid, L. Schantz, L. S. Haneline, A. Orazi, H. E. Broxmeyer, et al. Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis Blood, December 1, 2003; 102(12): 4146 - 4152. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Casson, S. C. Evans, A. Gillis, G. A. Porter, P. Veugelers, S. J. Darnton, D. L. Guernsey, and P. Hainaut Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: Results of a ten-year prospective study J. Thorac. Cardiovasc. Surg., May 1, 2003; 125(5): 1121 - 1131. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Keller and H. Lu p53 Serine 392 Phosphorylation Increases after UV through Induction of the Assembly of the CK2{middle dot}hSPT16{middle dot}SSRP1 Complex J. Biol. Chem., December 13, 2002; 277(51): 50206 - 50213. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Laurent and J.-P. Jaffrezou Signaling pathways activated by daunorubicin Blood, August 15, 2001; 98(4): 913 - 924. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Offer, I. Zurer, G. Banfalvi, M. Rehak, A. Falcovitz, M. Milyavsky, N. Goldfinger, and V. Rotter p53 Modulates Base Excision Repair Activity in a Cell Cycle-specific Manner after Genotoxic Stress Cancer Res., January 1, 2001; 61(1): 88 - 96. [Abstract] [Full Text] |
||||
![]() |
C. J. Kemp, S. Sun, and K. E. Gurley p53 Induction and Apoptosis in Response to Radio- and Chemotherapy in Vivo Is Tumor-Type-dependent Cancer Res., January 1, 2001; 61(1): 327 - 332. [Abstract] [Full Text] |
||||
![]() |
G. Xiao, A. Chicas, M. Olivier, Y. Taya, S. Tyagi, F. R. Kramer, and J. Bargonetti A DNA Damage Signal Is Required for p53 to Activate gadd45 Cancer Res., March 1, 2000; 60(6): 1711 - 1719. [Abstract] [Full Text] |
||||
![]() |
F. Moretti, S. Nanni, A. Farsetti, M. Narducci, M. Crescenzi, S. Giuliacci, A. Sacchi, and A. Pontecorvi Effects of Exogenous p53 Transduction in Thyroid Tumor Cells with Different p53 Status J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 302 - 308. [Abstract] [Full Text] |
||||
![]() |
E. C. Thornborrow and J. J. Manfredi One Mechanism for Cell Type-specific Regulation of the bax Promoter by the Tumor Suppressor p53 Is Dictated by the p53 Response Element J. Biol. Chem., November 19, 1999; 274(47): 33747 - 33756. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. P. Kelavkar and K. F. Badr Effects of mutant p53 expression on human 15-lipoxygenase-promoter activity and murine 12/15-lipoxygenase gene expression: Evidence that 15-lipoxygenase is a mutator gene PNAS, April 13, 1999; 96(8): 4378 - 4383. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Posner, P. G. Johnston, R. B. Tishler, J. Andersen, M. Fiorentino, P. M. Busse, L. A. Cavacini, A. D. Colevas, J. Clark, and C. M. Norris The Prognostic Value of Thymidylate Synthase and p53 Expression in Patients Treated with Induction Chemotherapy for Squamous Cell Carcinoma of the Head and Neck Oncologist, December 1, 1998; 3(6): 424 - 431. [Abstract] [Full Text] |
||||
![]() |
J. W. Wilson, D. M. Pritchard, J. A. Hickman, and C. S. Potten Radiation-Induced p53 and p21WAF-1/CIP1 Expression in the Murine Intestinal Epithelium : Apoptosis and Cell Cycle Arrest Am. J. Pathol., September 1, 1998; 153(3): 899 - 909. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Lanni and T. Jacks Characterization of the p53-Dependent Postmitotic Checkpoint following Spindle Disruption Mol. Cell. Biol., February 1, 1998; 18(2): 1055 - 1064. [Abstract] [Full Text] |
||||
![]() |
O. B. Chernova, M. V. Chernov, Y. Ishizaka, M. L. Agarwal, and G. R. Stark MYC Abrogates p53-Mediated Cell Cycle Arrest in N-(Phosphonacetyl)-L-Aspartate-Treated Cells, Permitting CAD Gene Amplification Mol. Cell. Biol., January 1, 1998; 18(1): 536 - 545. [Abstract] [Full Text] |
||||
![]() |
M. S. Eller, T. Maeda, C. Magnoni, D. Atwal, and B. A. Gilchrest Enhancement of DNA repair in human skin cells by thymidine dinucleotides: Evidence for a p53-mediated mammalian SOS response PNAS, November 11, 1997; 94(23): 12627 - 12632. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Teoh, M. Urashima, A. Ogata, D. Chauhan, J. A. DeCaprio, S. P. Treon, R. L. Schlossman, and K. C. Anderson MDM2 Protein Overexpression Promotes Proliferation and Survival of Multiple Myeloma Cells Blood, September 1, 1997; 90(5): 1982 - 1992. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wu, H. Huang, Z. Miner, and M. Kulesz-Martin Activities and response to DNA damage of latent and active sequence-specific DNA binding forms of mouse p53 PNAS, August 19, 1997; 94(17): 8982 - 8987. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Osborn and T. C. Chambers Role of the Stress-activated/c-Jun NH2-terminal Protein Kinase Pathway in the Cellular Response to Adriamycin and Other Chemotherapeutic Drugs J. Biol. Chem., November 29, 1996; 271(48): 30950 - 30955. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Di Leonardo, S P Linke, K Clarkin, and G M Wahl DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes & Dev., November 1, 1994; 8(21): 2540 - 2551. [Abstract] [PDF] |
||||
![]() |
R Dover, Y Jayaram, K Patel, and R Chinery p53 expression in cultured cells following radioisotope labelling J. Cell Sci., January 5, 1994; 107(5): 1181 - 1184. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |